Douglas Carr insider trades: Century Therapeutics (IPSC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Douglas reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | IPSC | ↓ Sell | 266 | $1.52 | $404 | Direct | Nov 5, 2026 (2d) |
| Sep 14, 2026 | IPSC | ↓ Sell | 1,658 | $1.93 | $3K | Direct | Sep 15, 2026 (1d) |
| Aug 3, 2026 | IPSC | ↓ Sell | 275 | $1.98 | $544 | Direct | Aug 5, 2026 (2d) |
| Jun 12, 2026 | IPSC | ↓ Sell | 1,654 | $2.23 | $4K | Direct | Jun 15, 2026 (3d) |
| Jun 8, 2026 | IPSC | ↓ Sell | 249 | $2.11 | $526 | Direct | Jun 9, 2026 (1d) |
| May 4, 2026 | IPSC | ↓ Sell | 264 | $2.34 | $618 | Direct | May 6, 2026 (2d) |
| Mar 12, 2026 | IPSC | ↓ Sell | 7,043 | $2.55 | $18K | Direct | Mar 16, 2026 (4d) |
| Mar 9, 2026 | IPSC | ↓ Sell | 247 | $2.54 | $626 | Direct | Mar 11, 2026 (2d) |
| Feb 3, 2026 | IPSC | ↓ Sell | 323 | $1.82 | $589 | Direct | Feb 5, 2026 (2d) |
| Dec 8, 2025 | IPSC | ↓ Sell | 257 | $0.53 | $137 | Direct | Dec 10, 2025 (2d) |
| Nov 3, 2025 | IPSC | ↓ Sell | 292 | $0.59 | $171 | Direct | Nov 5, 2025 (2d) |
| Sep 8, 2025 | IPSC | ↓ Sell | 263 | $0.50 | $132 | Direct | Sep 10, 2025 (2d) |
| Aug 4, 2025 | IPSC | ↓ Sell | 296 | $0.53 | $158 | Direct | Aug 6, 2025 (2d) |
| Jun 9, 2025 | IPSC | ↓ Sell | 4,904 | $0.62 | $3K | Direct | Jun 11, 2025 (2d) |
| May 5, 2025 | IPSC | ↓ Sell | 295 | $0.55 | $162 | Direct | May 7, 2025 (2d) |
| Mar 10, 2025 | IPSC | ↓ Sell | 1,240 | $0.61 | $763 | Direct | Mar 12, 2025 (2d) |
| Feb 3, 2025 | IPSC | ↓ Sell | 351 | $0.78 | $274 | Direct | Feb 5, 2025 (2d) |
| Nov 4, 2024 | IPSC | ↓ Sell | 283 | $1.23 | $347 | Direct | Nov 5, 2024 (1d) |
| Aug 5, 2024 | IPSC | ↓ Sell | 289 | $1.83 | $528 | Direct | Aug 7, 2024 (2d) |
| May 3, 2024 | IPSC | ↓ Sell | 257 | $3.11 | $798 | Direct | May 7, 2024 (4d) |
| Feb 6, 2024 | IPSC | ↓ Sell | 1,200 | $4.14 | $5K | Direct | Feb 7, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IPSC insiders
Open-market trades in the last 12 months
About Douglas Carr's insider trades
Douglas Carr is SVP Finance & Operations at Century Therapeutics (IPSC). Since Feb 6, 2024, Douglas has reported no open-market purchases and 21 sales worth $40K on SEC Form 4. In the last 12 months: 10 sales ($28K).
Their filings also include grants and awards (7 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IPSC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.